ResMed Inc.
MX ˙ BMV ˙ US7611521078
SecurityMX:RMD / ResMed Inc.
InstitutionSequoia Financial Advisors, LLC
Latest Disclosed Ownership6,431 shares
Latest Disclosed Value $ 1,443,638
Sequoia Financial Advisors, LLC reports 12.94% increase in ownership of RMD / ResMed Inc.

On April 30, 2026 - Sequoia Financial Advisors, LLC filed a 13F-HR form disclosing ownership of 6,431 shares of ResMed Inc. (MX:RMD) valued at $1,443,638 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 5,694 shares of ResMed Inc.. This represents a change in shares of 12.94% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F RESMED COM 761152107 6,431 737 12.94 1,444 5.25 0.0081
2026-02-03 2025-12-31 13F RESMED COM 761152107 5,694 245 4.50 1,372 -8.05 0.0076
2025-10-29 2025-09-30 13F RESMED COM 761152107 5,449 1,259 30.05 1,492 37.93 0.0091
2025-07-25 2025-06-30 13F RESMED COM 761152107 4,190 1,853 79.29 1,081 106.69 0.0074
2025-04-23 2025-03-31 13F RESMED COM 761152107 2,337 -165 -6.59 523 -8.57 0.0040
2025-08-08 2024-12-31 13F/A-1 RESMED COM 761152107 2,502 429 20.69 572 13.04 0.0055
2025-02-07 2024-12-31 13F RESMED COM 761152107 2,502 429 572 0.0055
2024-10-21 2024-09-30 13F RESMED COM 761152107 2,073 34 1.67 506 29.74 0.0054
2024-07-15 2024-06-30 13F RESMED COM 761152107 2,039 196 10.63 390 6.85 0.0047
2024-04-30 2024-03-31 13F RESMED COM 761152107 1,843 -614 -24.99 365 -13.51 0.0045
2024-01-26 2023-12-31 13F RESMED COM 761152107 2,457 2,457 423 0.0052
2023-11-08 2023-09-30 13F RESMED COM 761152107 0 -1,270 -100.00 0 -100.00
2023-08-08 2023-06-30 13F RESMED COM 761152107 1,270 157 14.11 278 13.99 0.0048
2023-04-25 2023-03-31 13F RESMED COM 761152107 1,113 10 0.91 244 6.11 0.0054
2023-02-10 2022-12-31 13F/A-1 RESMED COM 761152107 1,103 1,103 230 0.0056
2023-01-18 2022-12-31 13F RESMED COM 761152107 1,103 1,103 230 0.0052
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.